EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,000 | +11.7% | 2,772 | +48.6% | 0.00% | – |
| Q1 2022 | $77,000 | -8.3% | 1,866 | -3.6% | 0.00% | -100.0% |
| Q4 2021 | $84,000 | +25.4% | 1,936 | +45.1% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -27.2% | 1,334 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $92,000 | -39.5% | 1,466 | -10.4% | 0.00% | -50.0% |
| Q1 2021 | $152,000 | -55.9% | 1,637 | -57.5% | 0.00% | -60.0% |
| Q4 2020 | $345,000 | +807.9% | 3,855 | +985.9% | 0.01% | +400.0% |
| Q3 2020 | $38,000 | -83.2% | 355 | -87.2% | 0.00% | -75.0% |
| Q2 2020 | $226,000 | +1954.5% | 2,765 | +1162.6% | 0.00% | – |
| Q3 2019 | $11,000 | -26.7% | 219 | -28.4% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | +275.0% | 306 | +302.6% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 76 | +81.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |